The global scleral lens market size accounted for USD 327.04 billion in 2024 and is predicted to increase from USD 365.07 billion in 2025 to approximately USD 982.68 billion by 2034, expanding at a CAGR of 11.63% from 2025 to 2034. The increasing incidence of ocular disorders is the key factor driving the market's growth. Also, favorable reimbursement policies, coupled with the key benefits offered by scleral lenses, can fuel market growth further.
The global water for injection market size was estimated at USD 34.16 billion in 2024 and is predicted to increase from USD 37.99 billion in 2025 to approximately USD 87.39 billion by 2034, expanding at a CAGR of 9.70% from 2025 to 2034. The demand for injectable medications and biologics, as well as biosimilars, has increased, driving the need for high-quality water for injections.
The global ELISpot and FluoroSpot assay market size accounted for USD 311.82 million in 2024 and is predicted to increase from USD 331.59 million in 2025 to approximately USD 576.59 million by 2034, expanding at a CAGR of 6.33% from 2025 to 2034. The growth of the ELISpot and FluoroSpot assay market can be linked to the growing demand for advanced diagnostics solutions, increased focus on research activities for understanding disease mechanisms and increased adoption of advanced assay technologies.
The global surgical fluid waste management system market size accounted for USD 1.47 billion in 2024 and is predicted to increase from USD 1.59 billion in 2025 to approximately USD 3.32 billion by 2034, expanding at a CAGR of 8.50% from 2025 to 2034. The concern over health-associated infections has driven the adoption of surgical fluid waste management systems in healthcare infrastructure. The number of surgical procedures has increased.
The global medical digital imaging system market size was estimated at USD 36.51 billion in 2024 and is predicted to increase from USD 38.82 billion in 2025 to approximately USD 67.38 billion by 2034, expanding at a CAGR of 6.32% from 2025 to 2034. The increasing prevalence of chronic diseases globally, rising healthcare spending, rapid technological innovation in 3D and 4D imaging, and a surge in the aging population are among several factors expected to drive the growth of the medical digital imaging system market throughout the projection period.
The global enzyme immunoassay market size accounted for USD 17.80 billion in 2024 and is predicted to increase from USD 18.51 billion in 2025 to approximately USD 26.35 billion by 2034, expanding at a CAGR of 4.00% from 2025 to 2034. The enzyme immunoassay sector is expanding quickly because of an increased need for prompt disease detection and trustworthy, non-invasive methods.
The global pharmaceutical CDMO for formulations market size was estimated at USD 45.43 billion in 2024 and is predicted to increase from USD 48.85 billion in 2025 to approximately USD 96.57 billion by 2034, expanding at a CAGR of 7.90% from 2025 to 2034. The pharmaceutical CDMO formulation market expands because companies allocate more research and development funding to tackle rising drug complexity and pursue external partnerships to meet rising personal medication needs.
The global CRISPR-based gene editing market size was estimated at USD 4.04 billion in 2024 and is predicted to increase from USD 4.46 billion in 2025 to approximately USD 13.39 billion by 2034, expanding at a CAGR of 13.00% from 2025 to 2034. The increased demand for target medical treatment solutions is driving the market. The advancements in gene editing technologies and growth in the biotechnology sector are boosting the CRISPR-based gene editing research and development.
The global vendor neutral archive and pacs market size accounted for USD 4.03 billion in 2024 and is predicted to increase from USD 4.44 billion in 2025 to approximately USD 10.53 billion by 2034, expanding at a CAGR of 10.80% from 2025 to 2034. The growth of the vendor neutral archive and PACS market is driven by the growing amount of medical imaging data and the rapid transition toward digital imaging, generating a need for effective data management solutions. The high adoption of telemedicine and remote diagnostics underscores the necessity for accessible and shareable imaging data, supporting market growth.
The U.S. patient engagement solutions market size accounted for USD 6.41 billion in 2024 and is predicted to increase from USD 7.40 billion in 2025 to approximately USD 25.21 billion by 2034, expanding at a CAGR of 14.68% from 2025 to 2034. The demand for value-based care models has increased in the U.S., driving the market. Increased demand for personalized healthcare experiences and the adoption of telehealth further contribute to the market growth.
The global semi-solid dosage contract manufacturing market size accounted for USD 19.51 billion in 2024 and is predicted to increase from USD 21.70 billion in 2025 to approximately USD 56.50 billion by 2034, expanding at a CAGR of 11.22% from 2025 to 2034. The market is driven by rising topical treatment demand with modern drug delivery progress and cost savings from outsourcing with regulatory expertise and better patient drug usage.
The global carpal tunnel release systems market size accounted for USD 920 million in 2024 and is predicted to increase from USD 980 million in 2025 to approximately USD 1,740 million by 2034, expanding at a CAGR of 6.60% from 2025 to 2034. The carpal tunnel release systems market growth is attributed to advancing minimally invasive techniques, rising occupational risk factors, and increasing adoption of high-precision surgical solutions.
The global site management organization market size accounted for USD 10.04 billion in 2024 and is predicted to increase from USD 10.66 billion in 2025 to approximately USD 27.44 billion by 2034, expanding at a CAGR of 11.07% from 2025 to 2034. The growth of the site management organization market is driven by rising healthcare expenditures, increasing clinical trial activities, and increasing requirements for efficient site management support from pharmaceutical companies.
The global raman spectroscopy market size accounted for USD 1.37 billion in 2024 and is predicted to increase from USD 1.47 billion in 2025 to approximately USD 2.88 billion by 2034, expanding at a CAGR of 7.73% from 2025 to 2034. The growth of the Raman spectroscopy market is driven by the rising adoption in various industries. Furthermore, the increasing focus on drug development, in which Raman spectroscopy plays a crucial role, and rising R&D activities drive market growth.
The global vaccine storage and packaging market size accounted for USD 22.10 billion in 2024 and is predicted to increase from USD 23.29 billion in 2025 to approximately USD 37.39 billion by 2034, expanding at a CAGR of 5.40% from 2025 to 2034. The increasing production of vaccines is expected to drive the growth of the market during the forecast period.
The global fondaparinux market size accounted for USD 552.14 million in 2024 and is predicted to increase from USD 585.43 million in 2025 to approximately USD 991.60 million by 2034, expanding at a CAGR of 6.03% from 2025 to 2034. The market is driven by an aging population, rising cardiovascular diseases, R&D advancements, strengthening healthcare infrastructure, and regulatory approval benefits.
The global glycated albumin assay market size accounted for USD 625.52 million in 2024 and is predicted to increase from USD 676.81 million in 2025 to approximately USD 1,375.66 million by 2034, expanding at a CAGR of 8.20% from 2025 to 2034. The growth of the market is driven by the increasing prevalence of diabetes worldwide, growing demand for clinical diagnostic tests, rising healthcare spending, and increasing research and development activities. Moreover, the increasing need for personalized medicine and rapid technological advancements in diagnostic techniques are expected to boost the growth of the glycated albumin assay market throughout the projected period.
The global endometrial ablation market size accounted for USD 1.28 billion in 2024 and is predicted to increase from USD 1.35 billion in 2025 to approximately USD 2.15 billion by 2034, expanding at a CAGR of 5.32% from 2025 to 2034. Rising advancements in ablation techniques, increasing demand for minimally invasive procedures, and high demand for endometrial ablation devices are boosting the growth of the market.
The global consumer health contract manufacturing market size accounted for USD 127.05 billion in 2024 and is predicted to increase from USD 138.22 billion in 2025 to approximately USD 295.03 billion by 2034, expanding at a CAGR of 8.79% from 2025 to 2034. The increasing demand for consumer healthcare products and the rising awareness about health and wellness are expected to drive the growth of the market during the forecast period.
The global therapeutic hypothermia systems market size accounted for USD 304.12 million in 2024 and is predicted to increase from USD 318.81 million in 2025 to approximately USD 487.42 million by 2034, expanding at a CAGR of 4.83% from 2025 to 2034. The growth of the market is mainly driven by the rising awareness amongst healthcare professionals about the benefits of therapeutic hypothermia systems.
The global veterinary ophthalmology equipment market size is accounted for USD 1.05 billion in 2024 and is predicted to increase from USD 1.13 billion in 2025 to approximately USD 2.25 billion by 2034, expanding at a CAGR of 7.94% from 2025 to 2034. The growth of the veterinary ophthalmology equipment market is driven by increasing pet ownership across the world. Moreover, increasing government funding for non-profits, advocacy, NGOs, and shelter groups that focus on improving animals' lives contributes to market expansion.
The global precision genomic testing market size accounted for USD 15.57 billion in 2024 and is predicted to increase from USD 17.89 billion in 2025 to approximately USD 62.34 billion by 2034, expanding at a CAGR of 14.88% from 2025 to 2034. Advancements in genomic technologies are the key factor driving market growth. Also, the growing focus on personalized medicine coupled with the growing demand for precision genomic testing can fuel market growth further.
The global hysteroscopy procedures market size accounted for USD 4.84 billion in 2024 and is predicted to increase from USD 5.22 billion in 2025 to approximately USD 10.26 billion by 2034, expanding at a CAGR of 7.80% from 2025 to 2034. The hysteroscopy procedures market is driven by increasing gynecological disorders, advancements in hysteroscopy equipment, and government healthcare investments.
The global automated microbiology market size accounted for USD 7.95 billion in 2024 and is predicted to increase from USD 8.80 billion in 2025 to approximately USD 22.03 billion by 2034, expanding at a CAGR of 10.73% from 2025 to 2034. The growing incidence of infectious diseases across the globe is the key factor driving market growth. Also, increasing demand for precise and rapid microbial identification coupled with technological advancements in microbiology can fuel market growth further.Market Key Takeaways
The global canine atopic dermatitis market size was calculated at USD 3.21 billion in 2024 and is predicted to increase from USD 3.44 billion in 2025 to approximately USD 6.40 billion by 2034, expanding at a CAGR of 7.14% from 2025 to 2034. The market is growing rapidly because of the growing demand for timely diagnosis and efficient therapies emphasizing non-invasive and targeted therapies. This expansion is anticipated to address the changing requirements of pet owners and veterinary experts.
The global PD-1 inhibitor drugs market size accounted for USD 42.11 billion in 2024 and is predicted to increase from USD 48.69 billion in 2025 to approximately USD 179.77 billion by 2034, expanding at a CAGR of 15.62% from 2025 to 2034. The market is driven by rising cancer incidence, expanding regulatory approvals, advanced combination therapeutic approaches, and improved accessibility to innovative immunotherapy.
The global computational biology market size was calculated at USD 6.34 billion in 2024 and is predicted to increase from USD 7.18 billion in 2025 to approximately USD 21.95 billion by 2034, expanding at a CAGR of 13.22% from 2025 to 2034. The computational biology market is driven by ongoing launches of innovative computational platforms and tools, rising investments, integration of artificial intelligence and progress in multiomics research.
The global amyloidosis therapeutics market size accounted for USD 2.94 billion in 2024 and is predicted to increase from USD 3.18 billion in 2025 to approximately USD 6.45 billion by 2034, expanding at a CAGR of 8.18% from 2025 to 2034. The rising incidences of amyloidosis, increasing disposable incomes, favourable health insurance policies and rising patient awareness are the factors driving the growth of the amyloidosis therapeutics market.
The global companion animal health market size accounted for USD 9.03 billion in 2024 and is predicted to increase from USD 9.71 billion in 2025 to approximately USD 18.75 billion by 2034, expanding at a CAGR of 7.58% from 2025 to 2034. The global market growth is attributed to the growing spending and pet population, increasing pet humanization, and increasing rate of medical care for pets.
The global neurogenomics market size accounted for USD 1.72 billion in 2024 and is predicted to increase from USD 2.01 billion in 2025 to approximately USD 8.02 billion by 2034, expanding at a CAGR of 16.64% from 2025 to 2034.The achievements of sequencing, biobanks, and target therapy revolutionize the health and treatment of the brain. While the government and private investments are accelerated, direct consumer genetic testing makes neurogenomic information anytime.
The global chronic disease management market size accounted for USD 5.82 billion in 2024 and is predicted to increase from USD 6.61 billion in 2025 to approximately USD 20.87 billion by 2034, expanding at a CAGR of 13.62% from 2025 to 2034.The demand for chronic disease management is increasing due to the rising chronic disease prevalences especially in the urban areas due to the changing lifestyle patterns.
The global real-world data (rwd) market size was estimated at USD 1.64 billion in 2024 and is predicted to increase from USD 1.88 billion in 2025 to approximately USD 6.37 billion by 2034, expanding at a CAGR of 14.54% from 2025 to 2034. The market growth is attributed to the increasing adoption of real-world data in clinical research and personalized healthcare solutions.
The global retinal implants market size accounted for USD 54.10 million 2024 and is predicted to increase from USD 58.70 million in 2025 to approximately USD 122.32 million by 2034, expanding at a CAGR of 8.50% from 2025 to 2034. The retinal implants market is expanding rapidly due to the increase in retinal degenerative diseases, such as age-related macular degeneration and retinitis pigmentosa, necessitating early diagnosis and efficient therapies. Moreover, the need for customized vision restoration solutions and the emphasis on non-invasive and minimally invasive technologies in ophthalmic care are stimulating market growth.
The global human primary cell culture market size was calculated at USD 3.90 billion in 2024 and is predicted to increase from USD 4.33 billion in 2025 to approximately USD 11.17 billion by 2034, expanding at a CAGR of 11.10% from 2025 to 2034.The human primary cell culture market growth is driven by growing focus on developing innovative platforms, increased funding and government support, implementation of sustainable practices and ongoing research and development activities as well as clinical studies for creating safe and effective cell-based therapies.
The global guillain-barre syndrome diagnostics market size was estimated at USD 149.53 million in 2024 and is predicted to increase from USD 154.02 million in 2025 to approximately USD 200.96 million by 2034, expanding at a CAGR of 3.00% from 2025 to 2034. The increasing incidence of guillain-barre syndrome (GBS), the increasing elderly population, growing awareness regarding early screening, rising approval and surge in the launch of new products, and technological advancements in diagnostic techniques are among several factors expected to drive the growth of the guillain-barre syndrome diagnostics market throughout the projected period.
The global single-use bioprocessing connectors market size was estimated at USD 1.30 billion in 2024 and is predicted to increase from USD 1.51 billion in 2025 to approximately USD 5.64 billion by 2034, expanding at a CAGR of 15.80% from 2025 to 2034. Rising use of single-use bioprocessing systems is the key factor driving market growth. The surge in the production of biologics and biosimilars, coupled with innovations in the design of connectors, can fuel market growth further.
The global molecular weight marker market size was estimated at USD 789.12 million in 2024 and is predicted to increase from USD 887.76 million in 2025 to approximately USD 2,562.53 million by 2034, expanding at a CAGR of 12.50% from 2025 to 2034. The market growth is attributed to increasing demand for proteomics and genomics research and expanding applications in drug discovery and clinical diagnostics.
The global renal failure treatment market size was estimated at USD 122.03 billion in 2024 and is predicted to increase from USD 132.28 billion in 2025 to approximately USD 273.38 billion by 2034, expanding at a CAGR of 8.40% from 2025 to 2034. The Renal Failure Treatment Market is witnessing high growth because of the increasing incidence of chronic kidney diseases and end-stage renal disease. The need for early diagnosis and effective treatments has hastened the progress in renal care solutions. The market is growing because of the focus on individualized treatments and new technologies, such as wearable dialysis devices, which are intended to enhance patient outcomes and quality of life.
The global ashwagandha market size was estimated at USD 766.24 million in 2024 and is predicted to increase from USD 837.50 million in 2025 to approximately USD 1,864.51 million by 2034, expanding at a CAGR of 9.30% from 2025 to 2034. The expansion of the ashwagandha market is fostered by the increased emphasis on development of innovative products and growing consumer demand for naturally derived supplements. Furthermore, supportive government initiatives are creating opportunities for market growth.
The global clinical trial patient recruitment services market size was estimated at USD 980 million in 2024 and is predicted to increase from USD 1.06 billion in 2025 to approximately USD 2.14 billion by 2034, expanding at a CAGR of 8.11% from 2025 to 2034. The growth of the clinical trial patient recruitment services market is majorly driven by the increase in the number of clinical trials. Furthermore, the rising digitalization in clinical trials is fueling market expansion.
The global biotech ingredients market size was estimated at USD 2.40 billion in 2024 and is predicted to increase from USD 2.59 billion in 2025 to approximately USD 5.10 billion by 2034, expanding at a CAGR of 7.83% from 2025 to 2034. Advancements in biotechnology and rising demand for sustainable alternatives drive the growth of the biotech ingredients market.
The global image-based cytometry in cell analysis market size was estimated at USD 3.33 billion in 2024 and is predicted to increase from USD 3.68 billion in 2025 to approximately USD 8.98 billion by 2034, expanding at a CAGR of 10.43% from 2025 to 2034. The increased research activities for enhancing the efficacy of image-based cytometry, growing demand for cell-based therapies and rising adoption across the globe is driving the growth of the image-based cytometry in cell analysis market.
The global nucleic acid methylation market size was estimated at USD 3.46 billion in 2024 and is predicted to increase from USD 3.97 billion in 2025 to approximately USD 13.66 billion by 2034, expanding at a CAGR of 14.72% from 2025 to 2034. The growth of the market is driven by the growing use of methylation markers in disease detection. Furthermore, innovations in mass spectrometry and sequencing technologies and the surge in research funding in precision medicine can fuel the growth of the nucleic acid methylation market.
The global circRNA synthesis market size was estimated at USD 184.83 million in 2024 and is predicted to increase from USD 214.22 million in 2025 to approximately USD 808.36 million by 2034, expanding at a CAGR of 15.90% from 2025 to 2034. The market growth is attributed to increasing investment in RNA-based therapeutics and expanding applications in disease diagnostics and drug development.
The global optical coherence tomography market size was estimated at USD 2.23 billion in 2024 and is predicted to increase from USD 2.59 billion in 2025 to approximately USD 9.79 billion by 2034, expanding at a CAGR of 15.94% from 2025 to 2034. The demand for OCT devices has increased due to the rising prevalence of eye disorders. The growing need for early disease diagnosis and demand for non-invasive devices are driving the market.
The global cough assist devices market size was estimated at USD 235.85 billion in 2024 and is predicted to increase from USD 253.90 billion in 2025 to approximately USD 474.03 billion by 2034, expanding at a CAGR of 7.23% from 2025 to 2034. The increasing prevalence of respiratory and neuromuscular disorders among people of all age groups and the preferences for respiratory therapy or home-based medical care settings drive the expansion of the market.
The global patient identification wristbands market size was estimated at USD 1.47 billion in 2024 and is predicted to increase from USD 1.61 billion in 2025 to approximately USD 3.58 billion by 2034, expanding at a CAGR of 9.32% from 2025 to 2034. The demand for patient wristbands is driven by rising patient volumes in hospitals, which attract significant attention from companies.
The global organ preservation market size was estimated at USD 273.03 billion in 2024 and is predicted to increase from USD 290.86 billion in 2025 to approximately USD 513.96 billion by 2034, expanding at a CAGR of 6.53% from 2025 to 2034. Rising government initiatives to support organ donation programs and advancements in technology drive the organ preservation market.
The U.S. targeted DNA RNA sequencing market size was estimated at USD 4.02 billion in 2024 and is predicted to increase from USD 4.80 billion in 2025 to approximately USD 24.14 billion by 2034, expanding at a CAGR of 19.63% from 2025 to 2034. The demand for targeted sequencing in the country is attributed to the rising prevalence of genetic disorders and cancer incidences.
The global nutrigenomics market size was estimated at USD 521.62 million in 2024 and is predicted to increase from USD 613.01 million in 2025 to approximately USD 2,621.03 million by 2034, expanding at a CAGR of 17.52% from 2025 to 2034. The demand for personalized nutrition has increased, driving the global market. Growing awareness of genetic expression and nutrition is driving demands for genetic testing, leading the market to grow further.
The U.S. DNA nanotechnology market size was estimated at USD 1.61 billion in 2024 and is predicted to increase from USD 2.01 billion in 2025 to approximately USD 15.32 billion by 2034, expanding at a CAGR of 25.26% from 2025 to 2034. The demand for DNA nanotechnology is increasing due to the rising medical applications that aim to produce advanced drug delivery systems for various treatments.
The global angiography equipment market size was estimated at USD 11.12 billion in 2024 and is predicted to increase from USD 11.81 billion in 2025 to approximately USD 20.29 billion by 2034, expanding at a CAGR of 6.20% from 2025 to 2034. The growing application scope of angiography equipment is the key factor driving the market growth. Also, technological advancements coupled with the rising geriatric population are expected to fuel market growth shortly.
The U.S. dental consumables market size was estimated at USD 14.88 billion in 2024 and is predicted to increase from USD 16.08 billion in 2025 to approximately USD 32.29 billion by 2034, expanding at a CAGR of 8.06% from 2025 to 2034. The demand for dental consumables in the country is increasing due to the rising prevalence of dental disorders, leading to advancements in dental solutions.
The global trauma and extremities devices market size was estimated at USD 14.94 billion in 2024 and is predicted to increase from USD 15.73 billion in 2025 to approximately USD 24.90 billion by 2034, expanding at a CAGR of 5.24% from 2025 to 2034. Increased prevalence of orthopaedic disorders in the geriatric population driving the growth of the global market. Increased incidence of sports injuries has raised the need for trauma and extremities devices. Additionally, rising demand for minimally invasive procedures is emerging in the market.
The global bone metabolism tests market size was estimated at USD 2.91 billion in 2024 and is predicted to increase from USD 3.13 billion in 2025 to approximately USD 6.02 billion by 2034, expanding at a CAGR of 7.53% from 2025 to 2034. The global market growth is attributed to the introduction of innovative bone metabolism testing products.
The global orthopedic software market size accounted for USD 433.22 billion in 2024 and is predicted to increase from USD 458.52 billion in 2025 to approximately USD 764.21 billion by 2034, expanding at a CAGR of 5.84% from 2025 to 2034. The rising adaptation of digitization and technological innovations in the healthcare infrastructure drives the growth of the market.
The global massage oil market size accounted for USD 3.72 billion in 2024 and is predicted to increase from USD 3.99 billion in 2025 to approximately USD 7.48 billion by 2034, expanding at a CAGR of 7.24% from 2025 to 2034.The demand for massage therapy by elderly people, working professionals, and athletes for reducing pain and relaxation is driving the growth of the market.
The global veterinary sterilization container market size was calculated at USD 86.37 million in 2024 and is predicted to increase from USD 91.41 million in 2025 to approximately USD 152.21 million by 2034, expanding at a CAGR of 5.83% from 2025 to 2034.The market is expanding at a CAGR of 5.83% between 2025 and 2034. The rising demand for veterinary sterilization containers is attributed to the widespread infection and disease among animals; there is an increasing need to ensure animal safety.
The global healthcare digital twins market size was estimated at USD 902.63 million in 2024 and is predicted to increase from USD 1,136.59 million in 2025 to approximately USD 9,046.01 million by 2034, expanding at a CAGR of 25.92% from 2025 to 2034. The increasing adoption of this technology in the healthcare sector is the key factor driving market growth. Also, advancements in data analytics coupled with the increasing demand for personalized medicine can fuel market growth further.
The global essential oils and plant extract for livestock market size was estimated at USD 2.90 billion in 2024 and is predicted to increase from USD 3.08 billion in 2025 to approximately USD 5.31 billion by 2034, expanding at a CAGR of 6.24% from 2025 to 2034. The increasing use of essential oil & plant extracts-based feed to enhance the yield is the key factor driving market growth. Also, the rising product demand from the livestock market coupled with the escalating consumption of meat across the globe can drive market growth further.
The global operating room management market size was estimated at USD 3.05 billion in 2024 and is predicted to increase from USD 3.25 billion in 2025 to approximately USD 5.71 billion by 2034, expanding at a CAGR of 6.47% from 2025 to 2034. The demand for efficient resource utilization is the major driver of the global market. The expanding operating room capabilities and rising need for improved communication and collaborative solutions have increased demand for operating room management solutions. Additionally, the growing emphasis on advanced technology implementation with operating room management solutions is generating growth opportunities for the market.
The global RNA editing market size was estimated at USD 15.04 billion in 2024 and is predicted to increase from USD 15.95 billion in 2025 to approximately USD 27.01 billion by 2034, expanding at a CAGR of 6.03% from 2025 to 2034. The demand for RNA editing is increasing due to its increasing use in drug development, which can help develop enhanced therapies.
The global surgical planning software market size was calculated at USD 115.41 million in 2024 and is predicted to increase from USD 123.07 million in 2025 to approximately USD 219.50 million by 2034, expanding at a CAGR of 6.64% from 2025 to 2034. The increased demand for cloud-based platforms is the major driver of the global surgical planning software market. The demand for personalized medicine and minimally invasive surgical procedures has increased; as a result, the adoption of surgical planning software has expanded.
The global healthcare analytical testing services market size was estimated at USD 15.76 billion in 2024 and is predicted to increase from USD 17.09 billion in 2025 to approximately USD 35.47 billion by 2034, expanding at a CAGR of 8.45% from 2025 to 2034. The market is driven by the increase in outsourcing businesses of analytical testing services by pharmaceutical or medical device firms.
The global atherosclerosis drugs market size was estimated at USD 16.98 billion in 2024 and is predicted to increase from USD 17.60 billion in 2025 to approximately USD 24.25 billion by 2034, expanding at a CAGR of 3.63% from 2025 to 2034. The growing prevalence of obesity and diabetes are key drivers of the market. Additionally, the growing prevalence of cardiovascular disease is contributing to the market growth. An aging population is expected to fuel global market growth in the forecast period.
The global cell surface marker detection market size was estimated at USD 5.68 billion in 2024 and is predicted to increase from USD 6.16 billion in 2025 to approximately USD 12.81 billion by 2034, expanding at a CAGR of 8.47% from 2025 to 2034. The global market growth is attributed to the increasing demand for precision medicine.
The global blood cancer diagnostics market size was estimated at USD 10.90 billion in 2024 and is predicted to increase from USD 11.65 billion in 2025 to approximately USD 21.24 billion by 2034, expanding at a CAGR of 6.90% from 2025 to 2034. The increasing incidence of blood cancer, the rising elderly population, growing awareness regarding the early screening of relevant symptoms, and rapid technological advancements in diagnostic techniques are among several factors expected to drive the growth of the global blood cancer diagnostics market throughout the projected period.
The global cell and gene therapy CDMO market size was estimated at USD 6.31 billion in 2024 and is predicted to increase from USD 8.07 billion in 2025 to approximately USD 74.03 billion by 2034, expanding at a CAGR of 27.92% from 2025 to 2034. The rising demand to put specialized expertise, facilities, and regulatory knowledge into developing and manufacturing cell and gene therapy is fueling the CDMO market for cell and gene therapy.
The Europe Pharmaceutical CDMO market size was estimated at USD 42.58 billion in 2024 and is predicted to increase from USD 45.68 billion in 2025 to approximately USD 88.84 billion by 2034, expanding at a CAGR of 7.62% from 2025 to 2034. The market is gaining traction as it allows pharmaceutical companies to have access to specialized expertise, advanced manufacturing facilities, and regulatory compliance support, which are essential components for developing and producing new drugs.
The next generation bioprinting market is experiencing significant growth, driven by advancements in technology, expanding applications, and increasing demand across various end-user industries. The demand for next generation bioprinting is increasing due to the growing focus on drug development that focuses on providing accurate medical testing.
The global pharmaceutical impurity synthesis and isolation services market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.35 billion in 2025 to approximately USD 2.73 billion by 2034, expanding at a CAGR of 8.12% from 2025 to 2034. The market growth is attributed to increasing pharmaceutical R&D investments and advancements in analytical technologies for impurity detection.
The global advanced therapy medicinal products market size was estimated at USD 35.98 billion in 2024 and is predicted to increase from USD 42.04 billion in 2025 to approximately USD 170.47 billion by 2034, expanding at a CAGR of 16.83% from 2025 to 2034. The market growth is attributed to the increasing demand for personalized and innovative treatments for chronic and rare diseases.
The global electronic skin patches market size was estimated at USD 6.30 billion in 2024 and is predicted to increase from USD 6.96 billion in 2025 to approximately USD 17.10 billion by 2034, expanding at a CAGR of 10.50% from 2025 to 2034. The rising demand for a non-invasive and comfortable approach to monitoring vital signs and other physiological parameters contributes to the growth of the electronic skin patch market.
The global personalized genomics market size accounted for USD 10.73 billion in 2024 and is predicted to increase from USD 12.57 billion in 2025 to approximately USD 12.57 billion by 2034, expanding at a CAGR of 17.73 from 2025 to 2034. The market growth is attributed to the increasing demand for personalized healthcare solutions, driven by advancements in genomic technologies and the rising prevalence of chronic diseases.
The global contract development manufacturing organization outsourcing market size was estimated at USD 171.46 billion in 2024 and is predicted to increase from USD 200.60 billion in 2025 to approximately USD 824.16 billion by 2034, expanding at a CAGR of 17.00% from 2025 to 2034. The demand for contract development and manufacturing organization outsourcing market is attributed to the fact that it allows pharmaceutical companies access to specialized expertise, advanced technologies, and manufacturing capabilities.
The global DNA nanotechnology market size was estimated at USD 5.50 billion in 2024 and is predicted to increase from USD 6.88 billion in 2025 to approximately USD 51.36 billion by 2034, expanding at a CAGR of 25.03% from 2025 to 2034. The market growth is attributed to the rising adoption of DNA nanotechnology in drug delivery and diagnostic applications.
The global spatial genomics and transcriptomics market size was calculated at USD 288.35 million in 2024 and is predicted to increase from USD 323.53 million in 2025 to approximately USD 911.71 million by 2034, expanding at a CAGR of 12.20% from 2025 to 2034. The demand for single-cell analysis has increased, which is responsible for driving the global spatial genomics and transcriptomic market. The introduction of spatial genomics and transcriptomics analysis is drawing a positive impact on market growth. Additionally, the rising government investments and funding for pharmaceutical R&D are making space for market growth.
The global dental sterilization market size was calculated at USD 1.65 billion in 2024 and is predicted to increase from USD 1.80 billion in 2025 to approximately USD 3.84 billion by 2034, expanding at a CAGR of 8.82% from 2025 to 2034. The increasing prevalence of dental issues in the worldwide population and the demand for efficient disinfection of instruments and devices drive the growth of the market.
The global predictive biomarkers market size was estimated at USD 24.31 billion in 2024 and is predicted to increase from USD 28.88 billion in 2025 to approximately USD 136.24 billion by 2034, expanding at a CAGR of 18.81% from 2025 to 2034. The demand for early diagnosis and therapies has increased due to the rising prevalence of chronic disease, making the expansion of the predictive biomarkers market. The market further has witnessed significant growth due to increased demand for personalized medicines. The growing need for non-invasive technologies is projected to drive the market expansions.
The global biotechnology contract manufacturing market size was estimated at USD 21.07 billion in 2024 and is predicted to increase from USD 22.93 billion in 2025 to approximately USD 49.06 billion by 2034, expanding at a CAGR of 8.82% from 2025 to 2034. The demand for biotechnology is increasing due to the rising need for biopharmaceutical products, marking significant growth in product development.
The global next-generation mass spectrometer market size was calculated at USD 2.21 billion in 2024 and is predicted to increase from USD 2.37 billion in 2025 to approximately USD 4.43 billion by 2034, expanding at a CAGR of 7.22% from 2025 to 2034. The next-generation mass spectrometers experience rapid growth due to technological innovation, rising healthcare and pharmaceutical needs, environmental monitoring, government investments, and miniaturization for field applications.
The global collateral ligament stabilizer system market size was calculated at USD 2.24 billion in 2024 and is predicted to increase from USD 2.38 billion in 2025 to approximately USD 4.17 billion by 2034, expanding at a CAGR of 6.41% from 2025 to 2034. The development of the market is driven by factors like increasing sports injuries, demand for minimally invasive treatments, an aging population, technological advancements, and improved healthcare spending.
The global peptide api market size was estimated at USD 59.09 billion in 2024 and is predicted to increase from USD 62.01 billion in 2025 to approximately USD 95.79 billion by 2034, expanding at a CAGR of 4.95% from 2025 to 2034. The demand for Active Pharmaceutical Ingredients (API) is increasing due to the growing preference for targeted therapies marking significant advancements.
The global military and humanitarian trauma care market size was calculated at USD 7.51 billion in 2024 and is predicted to reach around USD 14.40 billion by 2034, expanding at a CAGR of 6.72% from 2025 to 2034. The demand for emergency medical response has increased in military forces; as a result, the military and humanitarian trauma care segment is boosting. The demands for telemedicine and automation in trauma care are driving the military and humanitarian trauma care market. Additionally, rising government spending on military and humanitarian services is projected to boost the market in the forecast period.
The global nocturia market size accounted for USD 4.01 billion in 2024 and is expected to exceed around USD 8.69 billion by 2034, growing at a CAGR of 8.05% from 2025 to 2034. The market growth is attributed to increasing awareness, technological advancements, and a rising demand for effective treatment options for nocturia.
The global melanin market size was calculated at USD 152.08 million in 2024 and is predicted to reach around USD 300.00 million by 2034, expanding at a CAGR of 7.03% from 2025 to 2034. The increasing demand for natural ingredients for UV protection and skin treatment in cosmetics and skin care products drives the growth of the market.
The global diabetic neuropathy market size was calculated at USD 4.50 billion in 2024 and is predicted to reach around USD 9.06 billion by 2034, expanding at a CAGR of 7.24% from 2025 to 2034. The increasing prevalence of diabetic neuropathy in geriatric patients already affected by diabetes and further innovations in the development of novel drugs in the treatment of conditions drive the growth of the market.
The global Cystatin C assay market size was calculated at USD 293.00 million in 2024 and is predicted to reach around USD 616.35 billion by 2034, expanding at a CAGR of 7.72% from 2025 to 2034. The Cystatin C testing market is propelled by the growing prevalence of CKD, improvements in diagnostic technologies, enhanced test accuracy, and greater investments in healthcare.
The global thin film drug manufacturing market size was calculated at USD 7.38 billion in 2024 and is predicted to reach around USD 15.07 billion by 2034, expanding at a CAGR of 7.40% from 2025 to 2034. The demand for convenient and easy-to-use drugs is driving the growth of the global market. The need for fewer side effects and improved adherence to treatment is leveraging the market growth.
The global non-hodgkin's lymphoma therapeutics market size calculated at USD 10.23 billion in 2024 and is predicted to reach around USD 20.94 billion by 2034, expanding at a CAGR of 7.43% from 2025 to 2034. The market is driven by the increasing incidence rate of non-Hodgkin’s Lymphoma, new product development, indication focus on personalized medicine and AI incorporation in diagnosis, governmental encouragement, and enhanced diagnostic tools to investigate early-stage disease.
The global MRI coils market size was calculated at USD 9.58 billion in 2024 and is predicted to reach around USD 22.08 billion by 2034, expanding at a CAGR of 8.71% from 2025 to 2034. Rising demand for diagnostic imaging procedures is the key factor driving market growth. Also, the increasing incidence of chronic disease coupled with technological advancements in imaging techniques can fuel market growth further.
The global single tooth implants and dental bridges market size was calculated at USD 5.83 billion in 2024 and is predicted to reach around USD 9.87 billion by 2034, expanding at a CAGR of 5.10% from 2025 to 2034. The rising demand for single-tooth implants and dental bridges is attributed to the growing need to replace missing teeth and help maintain oral health, including teeth and gyms.
The global retinal vein occlusion market size was calculated at USD 2.82 billion in 2024 and is predicted to reach around USD 5.45 billion by 2034, expanding at a CAGR of 6.81% from 2025 to 2034. The rising awareness about retinal vein occlusion (RVO) and growing regulatory approvals for treatment are the key drivers of the market. Additionally, accessibility audit training for healthcare professionals in rural areas is furthering this awareness in developing regions.
The global albendazole veterinary market size was calculated at USD 203.04 million in 2024 and is predicted to reach around USD 393.48 million by 2034, expanding at a CAGR of 6.84% from 2025 to 2034. The increasing parasitic infection in livestock is attracting the growth of the market. Additionally, various awareness campaigns are contributing to the market expansion.
The global opioid use disorder market size accounted for USD 5.31 billion in 2024 and is expected to exceed around USD 15.32 billion by 2034, growing at a CAGR of 11.18% from 2025 to 2034. The increasing rates of substance use disorders are the key factor driving the market growth. Also, rising government efforts to deal with these disorders, coupled with the increasing awareness of opioid use conditions, can fuel market growth shortly.
The global healthcare electronic data interchange market size accounted for USD 5.34 billion in 2024 and is expected to exceed around USD 13.38 billion by 2034, growing at a CAGR of 9.62% from 2025 to 2034. The expanding legal requirements for the interchange of electronic data drive the healthcare electronic data interchange market.
The global single cell sequencing market size accounted for USD 2.45 billion in 2024 and is expected to exceed around USD 9.91 billion by 2034, growing at a CAGR of 15.00% from 2025 to 2034. Technological advances in the field of genomics are the key factor driving market growth. Also, the increasing incidence of genetic diseases coupled with the collaboration among academic institutions can fuel market growth soon.
The global salt therapy market size accounted for USD 7.87 billion in 2024 and is expected to exceed around USD 19.05 billion by 2034, growing at a CAGR of 9.25% from 2025 to 2034. Increasing awareness about respiratory health is the key factor driving market growth. Also, the surge in wellness tourism coupled with the innovations in equipment and technology can fuel market growth further.
The global peek implants market size was calculated at USD 1.04 billion in 2024 and is predicted to reach around USD 2.23 billion by 2034, expanding at a CAGR of 7.95% from 2025 to 2034. The rising demand for medical materials with higher biocompatibility, great mechanical strength, and corrosion resistance drives the market's growth.
The global lentiviral vector market size accounted for USD 348.61 million in 2024 and is expected to exceed around USD 1,908.19 million by 2034, growing at a CAGR of 18.53% from 2025 to 2034. The market is driven by growth in gene therapy, enhanced research, artificial intelligence integration, FDA approval, and target-specific diseases.
